Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
54,486,781
-
Total 13F shares
-
389,880
-
Share change
-
+67,095
-
Total reported value
-
$4,807,906
-
Price per share
-
$12.36
-
Number of holders
-
17
-
Value change
-
+$1,046,852
-
Number of buys
-
11
-
Number of sells
-
2
Institutional Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q4 2025
As of 31 Dec 2025,
Emergent BioSolutions Inc. - Common Stock (EBS) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
389,880 shares.
The largest 10 holders included
Palumbo Wealth Management LLC, SILVER OAK SECURITIES, INCORPORATED, Assenagon Asset Management S.A., HARBOR CAPITAL ADVISORS, INC., SG Americas Securities, LLC, WEALTH ENHANCEMENT ADVISORY SERVICES, LLC, Baron Wealth Management LLC, Moisand Fitzgerald Tamayo, LLC, NISA INVESTMENT ADVISORS, LLC, and MassMutual Private Wealth & Trust, FSB.
This page lists
17
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.